NCT00648544View on ClinicalTrials.gov

Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Therapeutic Equivalency
Interventions
DRUG

Pravastatin

Single-dose 80 mg oral immediate-release tablet

DRUG

Pravastatin

Single-dose 80 mg oral immediate-release tablets

Trial Locations (1)

M1L 4S4

Biovail Contract Reseach, Toronto

Sponsors

Collaborators (1)

Genpharm ULC
All Listed Sponsors
collaborator

Genpharm ULC

INDUSTRY

lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648544 - Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects | Biotech Hunter | Biotech Hunter